Advertisement

Syphilis during pregnancy: a preventable threat to maternal-fetal health

Published:December 09, 2016DOI:https://doi.org/10.1016/j.ajog.2016.11.1052
      Syphilis remains the most common congenital infection worldwide and has tremendous consequences for the mother and her developing fetus if left untreated. Recently, there has been an increase in the number of congenital syphilis cases in the United States. Thus, recognition and appropriate treatment of reproductive-age women must be a priority. Testing should be performed at initiation of prenatal care and twice during the third trimester in high-risk patients. There are 2 diagnostic algorithms available and physicians should be aware of which algorithm is utilized by their testing laboratory. Women testing positive for syphilis should undergo a history and physical exam as well as testing for other sexually transmitted infections, including HIV. Serofast syphilis can occur in patients with previous adequate treatment but persistent low nontreponemal titers (<1:8). Syphilis can infect the fetus in all stages of the disease regardless of trimester and can sometimes be detected with ultrasound >20 weeks. The most common findings include hepatomegaly and placentomegaly, but also elevated peak systolic velocity in the middle cerebral artery (indicative of fetal anemia), ascites, and hydrops fetalis. Pregnancies with ultrasound abnormalities are at higher risk of compromise during syphilotherapy as well as fetal treatment failure. Thus, we recommend a pretreatment ultrasound in viable pregnancies when feasible. The only recommended treatment during pregnancy is benzathine penicillin G and it should be administered according to maternal stage of infection per Centers for Disease Control and Prevention guidelines. Women with a penicillin allergy should be desensitized and then treated with penicillin appropriate for their stage of syphilis. The Jarisch-Herxheimer reaction occurs in up to 44% of gravidas and can cause contractions, fetal heart rate abnormalities, and even stillbirth in the most severely affected pregnancies. We recommend all viable pregnancies receive the first dose of benzathine penicillin G in a labor and delivery department under continuous fetal monitoring for at least 24 hours. Thereafter, the remaining benzathine penicillin G doses can be given in an outpatient setting. The rate of maternal titer decline is not tied to pregnancy outcomes. Therefore, after adequate syphilotherapy, maternal titers should be checked monthly to ensure they are not increasing four-fold, as this may indicate reinfection or treatment failure.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Obstetrics & Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Bowen V.
        • Su J.
        • Torrone E.
        • Kidd S.
        • Weinstock H.
        Increase in incidence of congenital syphilis–United States 2012-2014.
        MMWR Morb Mortal Wkly Rep. 2015; 64: 1241-1245
        • Eccleston K.
        • Collins L.
        • Higgins S.P.
        Primary syphilis.
        Int J STD AIDS. 2008; 19: 145-151
        • Schmid G.P.
        • Stoner B.P.
        • Hawkes S.
        • et al.
        The need and plan for global elimination of congenital syphilis.
        Sex Transm Dis. 2007; 34: S5-S10
      1. World Health Organization, Department of Reproductive Health and Research. The global elimination of congenital syphilis: rationale and strategy for action. Available at: http://apps.who.int/iris/bitstream/10665/43782/1/9789241595858_eng.pdf. Accessed Aug. 20, 2016.

      2. World Health Organization. WHO validates elimination of mother to child transmission of HIV and syphilis in Cuba. Available at: http://www.who.int/reproductivehealth/topics/rtis/emtct-validation-cuba/en/. Accessed Aug. 15, 2016.

      3. World Health Organization. Thailand is first country in Asia to eliminate mother-to-child transmission of HIV and syphilis. Available at: http://www.searo.who.int/mediacentre/releases/2016/1627/en/. Accessed Aug. 15, 2016.

      4. World Health Organization. WHO validates elimination of mother-to-child transmission of HIV and syphilis in Armenia, Belarus and the Republic of Moldova. Available at: http://www.euro.who.int/en/media-centre/sections/press-releases/2016/06/who-validates-elimination-of-mother-to-child-transmission-of-hiv-and-syphilis-in-armenia,-belarus-and-the-republic-of-moldova. Accessed Aug. 15, 2016.

      5. Centers for Disease Control and Prevention. STD surveillance 2015. Available at: http://www.cdc.gov/std/stats15/syphilis.htm. Accessed Aug. 12, 2016.

        • Lukehart S.A.
        Syphilis.
        in: Longo D.L. Fauci A.S. Kasper D.L. Hauser S.L. Jameson J. Loscalzo J. Harrison's principles of internal medicine. 18th ed. McGraw-Hill, New York (NY)2012
        • Cunningham F.G.
        • Leveno K.J.
        • Bloom S.L.
        • Hauth J.C.
        • Rouse D.J.
        • Spong C.Y.
        Williams obstetrics.
        23rd ed. McGraw-Hill Medical, New York (NY)2010
      6. Centers for Disease Control and Prevention. STD treatment guidelines 2015. Available at: http://www.cdc.gov/std/tg2015/. Accessed July 15, 2016.

        • Hollier L.M.
        • Cox S.
        Syphilis.
        Semin Perinatol. 1998; 22: 323-331
        • Salooje H.
        • Velaphi S.
        • Goga Y.
        • Afadapa N.
        • Steen R.
        • Lincetto O.
        The prevention and management of congenital syphilis: an overview and recommendations.
        Bull World Health Organ. 2004; 82: 424-430
        • Qin J.
        • Yang T.
        • Xiao S.
        • Tan H.
        • Feng T.
        • Fu H.
        Reported estimates of adverse pregnancy outcomes among women with and without syphilis: a systematic review and meta-analysis.
        PLoS One. 2014; 9: e102203
        • Lubiganon P.
        • Piaggio G.
        • Villar J.
        • et al.
        WHO Antenatal Care Trial Research Group. The epidemiology of syphilis in pregnancy.
        Int J STD AIDS. 2001; 13: 486-494
        • Tong M.L.
        • Lin L.R.
        • Liu G.L.
        • et al.
        Factors associated with serological cure and the serofast state of HIV-negative patients with primary, secondary, latent and tertiary syphilis.
        PLoS One. 2013; 8: e70102
        • Ren R.X.
        • Wang L.N.
        • Zheng H.Y.
        • Li J.
        No improvement in serological response among serofast latent patients retreated with benzathine penicillin.
        Int J STD AIDS. 2016; 27: 58-62
        • Cantor A.G.
        • Pappas M.
        • Daeges M.
        • Nelson H.D.
        Screening for syphilis: updated evidence report and systemic review for the US Preventive Services Task Force.
        JAMA. 2016; 315: 2328-2337
        • Watson-Jones D.
        • Changalucha J.
        • Gumodoka B.
        • et al.
        Syphilis in pregnancy in Tanzania. I. Impact of maternal syphilis on outcomes of pregnancy.
        J Infect Dis. 2002; 186: 940-947
        • Larsen S.A.
        • Steiner B.M.
        • Rudolph A.H.
        Laboratory diagnosis and interpretation of tests for syphilis.
        Clin Microbiol Rev. 1995; 8: 1-21
      7. Association of Public Health Laboratories, Centers for Disease Control Prevention. Expert Consultation Meeting Summary Report. Available at: https://www.aphl.org/programs/infectious_disease/std/Documents/ID_2009Jan_Laboratory-Guidelines-Treponema-pallidum-Meeting-Report.pdf. Accessed August 23, 2016.

        • Centers for Disease Control and Prevention
        Discordant results from reverse sequence syphilis screening–five laboratories, United States, 2006-2010.
        MMWR Morb Mortal Wkly Rep. 2011; 60: 133-137
        • Mmeje O.
        • Chow J.M.
        • Davidson L.
        • Shieh J.
        • Schapiro J.M.
        • Park I.U.
        Discordant syphilis immunoassays in pregnancy: perinatal outcome and implications for clinical management.
        Clin Infect Dis. 2015; 61: 1049-1053
        • Park I.U.
        • Chow J.M.
        • Bolan G.
        • Stanley M.
        • Shieh J.
        • Schapiro J.M.
        Screening for syphilis with the treponemal immunoassay: analysis of discordant serology results and implications for clinical management.
        J Infect Dis. 2011; 204: 1297-1304
        • Hollier L.M.
        • Hill J.
        • Sheffield J.S.
        • Wendel Jr., G.D.
        State laws regarding prenatal syphilis screening in the United States.
        Am J Obstet Gynecol. 2003; 189: 1178-1183
        • Abyad A.
        Cost-effectiveness of antenatal screening for syphilis.
        Health Care Women Int. 1995; 16: 323-328
        • Connor N.
        • Roberts J.
        • Nicoll A.
        Strategic options for antenatal screening for syphilis in the UK.
        J Med Screen. 2000; 7: 7-13
        • US Preventive Services Task Force
        Screening for syphilis infection in pregnancy: US Preventive Services Task Force reaffirmation recommendation statement.
        Ann Intern Med. 2009; 150: 705-709
        • Albright C.M.
        • Emerson J.B.
        • Werner E.F.
        • Hughes B.L.
        Third trimester prenatal syphilis screening.
        Obstet Gynecol. 2015; 126: 479-485
        • Shiber L.
        • Todia W.J.
        Cost and clinical utility of repeated syphilis screening in third trimester pregnancy in a high-risk population.
        Am J Obstet Gynecol. 2014; 210: 267.e1-267.e5
        • Harter C.
        • Bernirschke K.
        Fetal syphilis in the first trimester.
        Am J Obstet Gynecol. 1976; 124: 705-711
        • Lawrence N.L.
        • Bohoman V.R.
        • Sanchez P.J.
        • Leos N.K.
        • Twickler D.M.
        • Wendel G.D.
        In utero infection with Treponema pallidum in early pregnancy.
        Prenat Diagn. 1997; 17: 119-123
        • Wendel Jr., G.D.
        • Sanchez P.J.
        • Peters M.T.
        • Harstad T.W.
        • Potter L.L.
        • Norgard M.V.
        Identification of Treponema pallidum in amniotic fluid and fetal blood from pregnancies complicated by congenital syphilis.
        Obstet Gynecol. 1991; 78: 890-894
        • Hollier L.M.
        • Harstad T.W.
        • Sanchez P.J.
        • Twickler D.M.
        • Wendel Jr., G.D.
        Fetal syphilis: clinical and laboratory characteristics.
        Obstet Gynecol. 2001; 97: 947-953
        • Rac M.W.F.
        • Bryant S.N.
        • McIntire D.D.
        • et al.
        Progression of ultrasound findings of fetal syphilis after maternal treatment.
        Am J Obstet Gynecol. 2014; 211: 426.e1-426.e6
        • Lawrence N.L.
        • Twickler D.M.
        • Peters M.T.
        • Sanchez P.J.
        • Wendel G.D.
        Fetal syphilis: correlation of sonographic findings and rabbit infectivity testing of amniotic fluid.
        J Ultrasound Med. 1993; 2: 97-101
        • Wendel G.D.
        • Maberry M.C.
        • Christmas J.T.
        • Goldberg M.S.
        • Norgard M.V.
        Examination of amniotic fluid in diagnosis congenital syphilis with fetal death.
        Obstet Gynecol. 1989; 74: 967-970
        • Daffos F.
        • Forestier F.
        • Grangeot-Keros L.
        • et al.
        Prenatal diagnosis of congenital rubella.
        Lancet. 1984; 2: 1-3
        • Wendel Jr., G.D.
        • Sheffield J.S.
        • Hollier L.M.
        • Hill J.B.
        • Ramsey P.S.
        • Sanchez P.J.
        Treatment of syphilis in pregnancy and prevention of congenital syphilis.
        Clin Infect Dis. 2002; 35: S200-S209
        • Rolfs R.T.
        Treatment of syphilis, 1993.
        Clin Infect Dis. 1995; 20: S23-S38
        • Levine Z.
        • Sherer D.M.
        • Jacobs A.
        • Rotenberg O.
        Nonimmune hydrops fetalis due to congenital syphilis associated with negative intrapartum maternal serology screening.
        Am J Perinatol. 1998; 15: 233-236
        • Hira S.K.
        • Bhat G.J.
        • Patel J.B.
        • et al.
        Early congenital syphilis: clinico-radiologic features in 202 patients.
        Sex Transm Dis. 1985; 12: 177-183
        • Long W.A.
        • Ulshen M.H.
        • Lawson E.E.
        Clinical manifestations of congenital syphilitic hepatitis: implications for pathogenesis.
        J Pediatr Gastroenterol Nutr. 1984; 3: 551-555
        • Anand N.K.
        • Chellani H.K.
        • Wadhwa A.
        • Prasanna S.B.
        • Mohan M.
        Congenital syphilitic hepatitis.
        Indian Pediatr. 1991; 28: 157-159
        • Sheffield J.S.
        • Sanchez P.J.
        • Wendel Jr., G.D.
        • et al.
        Placental histopathology of congenital syphilis.
        Obstet Gynecol. 2002; 100: 126-133
        • Qureshi F.
        • Jacques S.M.
        • Reyes M.P.
        Placental histopathology in syphilis.
        Hum Pathol. 1993; 24: 779-784
        • Genest D.R.
        • Choi-Hong S.R.
        • Tate J.E.
        • Qureshi F.
        • Jacques S.M.
        • Crum C.
        Diagnosis of congenital syphilis from placental examination: comparison of histopathology, Steiner stain, and polymerase chain reaction for Treponema pallidum DNA.
        Hum Pathol. 1996; 27: 366-372
        • Lucas M.J.
        • Theriot S.K.
        • Wendel Jr., G.D.
        Doppler systolic-diastolic ratios in pregnancies complicated by syphilis.
        Obstet Gynecol. 1991; 77: 217-222
        • Whitaker J.A.
        • Sartain P.
        • Shaheedy M.
        Hematological aspects of congenital syphilis.
        J Pediatr. 1965; 66: 629-636
        • Yarali N.
        • Balaban I.
        • Akyurek N.
        • Ucar S.
        • Zorlu P.
        Hemophagocytosis: the cause of anemia and thrombocytopenia in congenital syphilis.
        Pediatr Hematol Oncol. 2009; 26: 461-466
        • Alexander J.M.
        • Sheffield J.S.
        • Sanchez P.J.
        • Mayfield J.
        • Wendel G.D.
        Efficacy of treatment for syphilis in pregnancy.
        Obstet Gynecol. 2001; 93: 5-8
        • Hawkes S.J.
        • Gomez G.B.
        • Broutet N.
        Early antenatal care: does it make a difference to outcomes of pregnancy associated with syphilis? A systematic review and meta-analysis.
        PLoS One. 2013; 8: 1-7
        • Zhang Xh
        • Xu J.
        • Chen D.Q.
        • Guo L.F.
        • Qiu L.Q.
        Effectiveness of treatment to improve pregnancy outcomes among women with syphilis in Zhejiang Province, China.
        Sex Transm Infect. 2016; 92: 537-541
        • Collart P.
        • Poitevin M.
        • Milovanovic A.
        • et al.
        Kinetic study of serum penicillin concentrations after single doses of benzathine and benethamine penicillins in young and old people.
        Br J Vener Dis. 1980; 56: 355-362
        • Hagdrup H.K.
        • Lange W.G.
        • Secher L.
        • et al.
        Penicillin concentrations in serum following weekly injections of benzathine penicillin G.
        Chemotherapy. 1986; 32: 99-101
        • Frentz G.
        • Neilsen P.B.
        • Espersen F.
        • et al.
        Penicillin concentrations in blood and spinal fluid after a single intramuscular injection of penicillin G benzathine.
        Eur J Clin Microbiol. 1984; 3: 147-149
        • Nathan L.
        • Bawdon R.E.
        • Sidawi J.E.
        • et al.
        Penicillin levels following the administration of benzathine penicillin G in pregnancy.
        Obstet Gynecol. 1993; 82: 338-342
        • Walker G.J.
        Antibiotics for syphilis diagnosed during pregnancy.
        Cochrane Database Syst Rev. 2001; 3: CD001143
        • Weeks J.W.
        • Myers S.R.
        • Lasher L.
        • Goldsmith J.
        • Watkins C.
        • Gall S.A.
        Persistence of penicillin G benzathine in pregnant group B streptococcus carriers.
        Obstet Gynecol. 1997; 90: 240-243
        • Myer L.
        • Abdool Karim S.S.
        • Lombard C.
        • Wilkinson D.
        Treatment of maternal syphilis in rural South Africa: effect of multiple doses of benzathine penicillin on pregnancy loss.
        Trop Med Int Health. 2004; 9: 1216-1221
        • Donders G.G.
        • Desmyter J.
        • Hooft P.
        • Dewet G.H.
        Apparent failure of one injection of benzathine penicillin G for syphilis during pregnancy in human immunodeficiency virus-seronegative African women.
        Sex Transm Dis. 1997; 24: 94-101
        • Zhu L.
        • Qin M.
        • Du L.
        • Xie R.
        • Wong T.
        • Wen S.W.
        Maternal and congenital syphilis in Shanghai, China, 2002-2006.
        Int J Infect Dis. 2010; 14: e45-e48
        • Rac M.W.F.
        • Bryant S.N.
        • Cantey J.B.
        • McIntire D.D.
        • Wendel Jr., G.D.
        • Sheffield J.S.
        Maternal titers after adequate syphilotherapy during pregnancy.
        Clin Infect Dis. 2015; 60: 686-690
        • Sheffield J.S.
        • Sanchez P.J.
        • Morris G.
        • et al.
        Congenital syphilis after maternal treatment for syphilis during pregnancy.
        Am J Obstet Gynecol. 2002; 186: 569-573
        • Mascola L.
        • Pelosi R.
        • Alexander C.R.
        Inadequate treatment of syphilis in pregnancy.
        Am J Obstet Gynecol. 1984; 150: 945-947
        • McFarlin B.L.
        • Bottoms S.F.
        • Dock B.S.
        • Isada N.B.
        Epidemic syphilis: maternal factors associated with congenital infection.
        Am J Obstet Gynecol. 1994; 1709: 535-540
        • Ricci J.M.
        • Fojaco R.M.
        • O’Sullivan M.J.
        Congenital syphilis: the University of Miami/Jackson Memorial Medical Center experience, 1986-1988.
        Obstet Gynecol. 1989; 74: 687-693
        • Idsoe O.
        • Guthe T.
        • Wilcox R.R.
        Penicillin in the treatment of syphilis: the experience of three decades.
        Bull World Health Organ. 1972; 47: 1-68
        • Wendel Jr., G.D.
        • Stark B.J.
        • Jamison R.B.
        • Molina R.D.
        • Sullivan T.J.
        Penicillin allergy and desensitization in serious infections during pregnancy.
        N Engl J Med. 1985; 312: 1229-1232
        • Borish L.
        • Tamir R.
        • Rosenwasser L.J.
        Intravenous desensitization to beta-lactam antibiotics.
        J Allergy Clin Immunol. 1987; 80: 314-319
        • Stamm L.V.
        Global challenge of antibiotic-resistant Treponema pallidum.
        Antimicrob Agents Chemother. 2010; 54: 583-589
        • Zhou P.
        • Gu Z.
        • Xu J.
        • Wang X.
        • Liao K.
        A study evaluating ceftriaxone as a treatment agent for primary and secondary syphilis in pregnancy.
        Sex Transm Dis. 2005; 32: 495-498
        • Brown S.T.
        Adverse reactions in syphilis therapy.
        J Am Vener Dis Assoc. 1976; 3: 172-176
        • Loveday C.
        • Bingham J.S.
        Changes in circulating immune complexes during the Jarisch Herxheimer reaction in secondary syphilis.
        Eur J Clin Microbiol Infect Dis. 1993; 12: 185-191
        • Klein V.R.
        • Cox S.M.
        • Mitchell M.D.
        • Wendel Jr., G.D.
        The Jarisch-Herxheimer reaction complicating syphilotherapy in pregnancy.
        Obstet Gynecol. 1990; 75: 375-380
        • Aronson I.K.
        • Soltani K.
        The enigma of the pathogenesis of the Jarisch-Herxheimer reaction.
        Br J Vener Dis. 1976; 52: 313-315
        • Putkonen T.
        • Rehtjawi K.
        Febrile Herxheimer reaction in neurosyphilis.
        Acta Derm Venereol. 1951; 31: 120-132
        • Rac M.W.F.
        • Greer L.G.
        • Wendel Jr., G.D.
        Jarisch-Herxheimer reaction triggered by group B streptococcus intrapartum antibiotic prophylaxis.
        Obstet Gynecol. 2010; 116: 552-556
        • Farmer T.W.
        Jarisch-Herxheimer reaction in early syphilis.
        JAMA. 1948; 138: 480-485
        • Myles T.D.
        • Elam G.
        • Park-Hwang E.
        • Nguyen T.
        The Jarisch-Herxheimer reaction and fetal monitoring changes in pregnant women treated for syphilis.
        Obstet Gynecol. 1998; 92: 859-864
        • Lentz J.W.
        • Ingraham N.R.
        • Beerman H.
        • Stokes J.H.
        Penicillin in the prevention and treatment of congenital syphilis.
        JAMA. 1944; 126: 408-413
        • Beerman I.L.
        • Ingraham N.R.
        Recent advances in the management of the syphilitic pregnant woman.
        Med Clin North Am. 1945; 9: 1463-1476
        • Ingraham N.R.
        • Stokes J.H.
        • Beerman H.
        • Lentz J.W.
        • Wammock V.S.
        Penicillin treatment of the syphilitic pregnant woman.
        JAMA. 1946; 130: 683-688
        • Bowen J.H.
        • Cole H.N.
        • Driver J.R.
        • et al.
        Herxheimer reactions in penicillin treatment of syphilis in pregnancy.
        Arch Dermatol Syphilol. 1948; 58: 735-739
        • Cross J.B.
        • McCain J.R.
        • Herman A.
        The use of crystalline penicillin G in the treatment of syphilis in pregnancy.
        Am J Obstet Gynecol. 1949; 57: 461-465
        • Thompson S.E.
        Treatment of syphilis in pregnancy.
        J Am Vener Dis Assoc. 1976; 3: 159-166
        • Mascola L.
        • Pelosi R.
        • Blount J.H.
        • Alexander C.E.
        • Cates Jr., W.
        Congenital syphilis revisited.
        Am J Dis Child. 1985; 139: 575-580
        • Wallace H.E.
        • Isitt C.E.
        • Broomhall H.M.
        • Perry A.E.
        • Wilson J.D.
        Adverse pregnancy outcomes following syphilis treatment in pregnancy in the UK.
        Int J STD AIDS. 2016; 27: 1108-1113
        • Beksinska M.E.
        • Mullick S.
        • Kunene B.
        • Rees H.
        • Deperthes B.
        A case study of antenatal syphilis screening in South Africa: success and challenges.
        Sex Transm Dis. 2002; 29: 32-37
        • Vintzileos A.M.
        • Neckles S.
        • Campbell W.A.
        • et al.
        Fetal liver ultrasound measurements during normal pregnancy.
        Obstet Gynecol. 1985; 66: 477-480
        • Hoddick W.K.
        • Mahoney B.S.
        • Callen P.W.
        • Filley R.A.
        Placental thickness.
        J Ultrasound Med. 1985; 4: 179-182
        • Mari G.
        • Deter R.L.
        • Carpenter R.L.
        • et al.
        Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization.
        N Engl J Med. 2000; 342: 9-14
        • Moore T.R.
        • Cayle J.E.
        The amniotic fluid index in normal human pregnancy.
        Am J Obstet Gynecol. 1990; 162: 1168-1173
        • Norton M.E.
        • Chauhan S.P.
        • Dashe J.S.
        • Society for Maternal-Fetal Medicine (SMFM)
        Society for Maternal-Fetal Medicine (SMFM) clinical guideline no. 7: nonimmune hydrops fetalis.
        Am J Obstet Gynecol. 2015; 212: 127-139
        • Peeling R.W.
        • Ye H.
        Diagnostic tools for preventing and managing maternal and congenital syphilis: an overview.
        Bull World Health Organ. 2004; 84: 439-446